Challenges in Optimizing Treatment
- Combining Immune Checkpoint Inhibition with Targeted Therapy: Ross Soo
- Combining Immune Checkpoint Inhibition with Radiotherapy: Matthias Guckenberger
- Moving Beyond PD-L1 / PD1 Targeting: Stefan Zimmermann
- Discussion